Skip to main content
. 2018 Apr 26;35(6):588–594. doi: 10.1177/0885066618772498

Table 1.

Comparison Between Survivor and Nonsurvivor Patients With ARDS.

Characteristics Survivors Death P
Number of patients 328 196
Age, mean (SD) 60.3 (16.5) 64.2 (5.4) .07
Male gender, n (%) 192 (58.5) 118 (60.2) .77
Admission type, n (%) .77
 Medical 256 (78.0) 148 (75.5)
 Surgical 54 (16.5) 37 (18.9)
 Trauma 18 (5.5) 11 (5.6)
SAPS 2, mean (SD) 48.2 (18.7) 55.9 (18.6) <.001
Barthel, mean (SD) 85.4 (28.3) 81.3 (29.4) .11
SOFA, mean (SD) 8.4 (3.9) 9.6 (4.0) .001
COPD, n (%) 45 (13.7) 26 (13.3) .99
Chronic renal failure, n (%) 40 (12.2) 33 (16.8) .18
Diabetes, n (%) 69 (21.0) 53 (27.0) .14
Alcoholism, n (%) 28 (8.5) 19 (9.7) .77
Nonmetastatic cancer, n (%) 28 (8.5) 29 (14.8) .04
Metastatic cancer, n (%) 5 (1.5) 10 (5.1) .03
Hematologic cancer, n (%) 12 (3.7) 24 (12.2) <.001
AIDS, n (%) 2 (0.6) 5 (2.6) .14
Worsening X-ray, n (%) 42 (12.8) 33 (16.8) .25
Worsening gas exchange, n (%) 48 (14.6) 42 (21.4) .06
Time to infection, median (IQR) 7.0 (4.0-11.0) 8.0 (5.0-12.2) .12
VA-LRTI, % .26
 None 266 (81.1) 148 (75.5)
 VAT 32 (9.8) 22 (11.2)
 VAP 30 (9.1) 26 (13.3)

Abbreviations: AIDS, acquired immunodeficiency syndrome; ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SAPS 2, Simplified Acute Physiology Score 2; SD, standard deviation; SOFA, Sequential Organ Failure Assessment; VA-LRTI, ventilator-associated lower respiratory tract infections; VAP, ventilator-associated pneumonia; VAT, ventilator-associated tracheobronchitis.